Soy Lecithin vs Inulin: which is worse?

What is Soy Lecithin?

Soy lecithin is a phospholipid mixture extracted from soybeans during oil processing, primarily composed of phosphatidylcholine, phosphatidylethanolamine, and phosphatidylinositol. It is one of the most widely used food emulsifiers globally. Most commercial soy lecithin is derived from genetically modified soybeans, though organic varieties are available.

What is Inulin?

Inulin is a naturally occurring prebiotic dietary fiber (fructan polysaccharide) found in chicory root, Jerusalem artichoke, garlic, onions, and bananas. Commercial inulin is extracted primarily from chicory root. It resists digestion in the small intestine and is fermented by beneficial gut bacteria in the colon, promoting growth of Bifidobacterium and Lactobacillus species.

Documented risks

Soy Lecithin: Generally recognized as safe. Soy lecithin is highly refined, and most soy proteins that trigger allergies are removed during processing; however, highly soy-allergic individuals may react. EFSA conducted a safety re-evaluation in 2017 and confirmed its safety at current use levels. The majority of commercial soy lecithin comes from GMO soybeans, which some consumers prefer to avoid. No major toxicological risks have been identified at normal dietary exposure levels.

Inulin: Generally safe and beneficial. At doses above 15–20 g/day, inulin commonly causes bloating, gas, abdominal cramping, and diarrhea due to rapid fermentation in the colon. This is well documented in peer-reviewed research. It is contraindicated for people with fructan intolerance or irritable bowel syndrome following a low-FODMAP diet. At normal food fortification levels (3–8 g/serving), it is tolerated by most adults.